Explore how bridging studies ensure the safety and efficacy of NTI generic drugs. Learn about strict bioequivalence standards, study designs, and why these rigorous tests protect patients.
DetailsThe FDA ensures generic drugs are as safe and effective as brand-name drugs through strict approval standards, factory inspections, and ongoing monitoring. Learn how bioequivalence, cGMP, and post-market surveillance protect patients.
DetailsGeneric drugs must meet the same safety, strength, and quality standards as brand-name drugs. The FDA's rigorous approval process ensures bioequivalence, consistent manufacturing, and reliable performance-making generics safe, effective, and affordable.
Details